Page 45 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sittner & Nelson LLC lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 26.7% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 95 shares of the biopharmaceutical company’s stock after buying an additional 20 shares during the quarter. Sittner & Nelson LLC’s holdings in Regeneron Pharmaceuticals were worth $78,000 as […]

Biondo Investment Advisors LLC lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,005 shares of the biopharmaceutical company’s stock after purchasing an additional 125 shares […]

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) Director Bonnie L. Bassler sold 853 shares of the stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $789.00, for a total transaction of $673,017.00. Following the completion of the transaction, the director now owns 1,247 shares of the […]

Twin Capital Management Inc. cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,638 shares of the biopharmaceutical company’s stock after selling 529 shares during the quarter. Twin Capital Management Inc.’s […]

Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price boosted by Royal Bank of Canada from $818.00 to $820.00 in a research report report published on Friday morning, Benzinga reports. They currently have a sector perform rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the stock. SVB […]